Avita Medical | 1811094D - 売上総利益

株価
1.14
毎日の変更
0.01 0.44%
毎月
-10.98%
毎年
-61.13%
Q1 予測
1.23


金融部門
株価
AUD
資産
AUD 56.39M
現金と同等
AUD 10.24M
売上原価
AUD 3.3M
流動資産
AUD 35.49M
流動負債
AUD 62.68M
負債
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
従業員
AUD 87
株当たりのEPS利益
AUD -0.38
自己資本および準備金
AUD -16.65M
売上総利益
AUD 14.31M
債務の支払利息
AUD 1.25M
借入資本
AUD 42.25M
時価総額
AUD 154.06M
当期純利益
AUD -11.62M
営業経費
AUD 28.02M
営業利益
AUD -10.41M
税引前利益
AUD -11.64M
販売収入
AUD 17.62M
販売および管理費
AUD 19.03M
株式
AUD 6.93M
貿易債権者
AUD 8.96M
貿易債務者
AUD 9.11M


売上総利益 変化する 日付
Accuray USD 41.89M 7.42M 2024-12
Celltrion KRW 626.11B 81.75B 2025-09
Clinuvel Pharmaceuticals AUD 57.82M 18.86M 2024-06
Cochlear AUD 856.8M 430M 2025-12
CSL USD 4.46B 2.71B 2025-12
Cspc Pharmaceutical CNY 4.34B 333.68M 2025-09
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Mayne Pharma AUD 86.13M 18.92M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Nanosonics AUD 78.01M 3.95M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pacific Edge NZD 5.2M 1.75M 2024-06
Paradigm Biopharmaceuticals AUD -9K 423.94K 2025-06
Pharma Mar EUR 86.7M 53.34M 2025-12
Polynovo AUD 61.26M 38M 2025-12
PYC Therapeutics AUD 5.83M 750K 2025-06
Qiagen NV USD 325.27M 19.53M 2025-12
Ramsay Health Care AUD 549.95M 5.77B 2025-06
ResMed USD 886.53M 65.71M 2025-12
Sartorius EUR 393.2M 23M 2025-09
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Telix Pharmaceuticals AUD 217.82M 9.23M 2025-12
Tilray USD 57.47M 10.16M 2025-06
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06